澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

AROVELLA THERAPEUTICS LTD

0.099

0.000

成交量：62.39万

成交额：6.24万

市值：1.19亿

市盈率：-14.47

高：0.100

开：0.099

低：0.099

收：0.099

52周最高：0.195

52周最低：0.068

股本：12.01亿

流通股本：8.96亿

量比：1.07

换手率：0.07%

股息：- -

股息率：- -

每股收益(TTM):-0.007

每股收益(LYR):-0.007

净资产收益率：-47.98%

总资产收益率：-28.30%

市净率：5.92

市盈率(LYR):-14.47

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

Arovella Therapeutics向美国FDA提交Ala-101首次人体一期试验新药研究申请

Arovella Therapeutics Ltd的CAR-iNKT细胞平台美国专利申请获准授权

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ALA.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ALA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ALA.AU\",,,,,undefined,":{"symbol":"ALA.AU","market":"AU","secType":"STK","nameCN":"AROVELLA THERAPEUTICS LTD","latestPrice":0.099,"timestamp":1770684237756,"preClose":0.099,"halted":0,"volume":623891,"delay":0,"changeRate":0,"nameEN":"AROVELLA THERAPEUTICS LTD","floatShares":895858885,"shares":1201183672,"eps":-0.006843,"marketStatus":"交易中","change":0,"latestTime":"02-10 11:56:29 AEDT","open":0.099,"high":0.1,"low":0.099,"amount":62381,"amplitude":0.010101,"askPrice":0.105,"askSize":567995,"bidPrice":0.099,"bidSize":18561,"shortable":3,"etf":0,"ttmEps":-0.006843,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770699600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.099,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":1.072406,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ALA.AU\",,,,,undefined,":{"symbol":"ALA.AU","floatShares":895858885,"roa":"-28.30%","roe":"-47.98%","lyrEps":-0.006843,"volumeRatio":1.072406,"shares":1201183672,"dividePrice":0,"high":0.1,"amplitude":0.010101,"preClose":0.099,"low":0.099,"week52Low":0.068,"pbRate":"5.92","psRate":"34.57","week52High":0.195,"institutionHeld":0,"latestPrice":0.099,"committee":-0.936712,"eps":-0.006843,"divideRate":0,"volume":623891,"delay":0,"ttmEps":-0.006843,"open":0.099,"prevYearClose":0.093,"prevWeekClose":0.09,"prevMonthClose":0.086,"prevQuarterClose":0.093,"fiveDayClose":0.1,"twentyDayClose":0.094,"sixtyDayClose":0.096},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALA.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1138242283","title":"Arovella Therapeutics向美国FDA提交Ala-101首次人体一期试验新药研究申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1138242283","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138242283?lang=zh_cn&edition=fundamental","pubTime":"2025-12-30 09:19","pubTimestamp":1767057555,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics Ltd宣布已正式向美国食品药品监督管理局提交Ala-101的新药临床试验申请，该项申请旨在启动该药物的首次人体一期临床试验。这一重要进展标志着公司创新疗法开发迈入新的阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALA.AU","BK7096"],"gpt_icon":0},{"id":"1121490968","title":"Arovella Therapeutics Ltd的CAR-iNKT细胞平台美国专利申请获准授权","url":"https://stock-news.laohu8.com/highlight/detail?id=1121490968","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121490968?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 06:29","pubTimestamp":1756333754,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics Ltd的CAR-iNKT细胞平台美国专利申请将获得授权批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALA.AU","BK7096"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ALA.AU\",params:#limit:6,delay:true,,,undefined,":[]}}